Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (51-60 of 548) with videos related to

Pageof 55
Sort By:
Bulletin Du Cancer|March 2, 2023
[Homologous recombination deficiency in epithelial ovarian cancers: from molecular characterization to patient journey]Stanislas Quesada, Jérôme Solassol, Isabelle Ray-Coquard, et al.
Seminars in Cancer Biology|September 15, 2020
Challenges for immunotherapy for the treatment of platinum resistant ovarian cancerOlivia Le Saux, Isabelle Ray-Coquard, S Intidhar Labidi-Galy
Bulletin Du Cancer|September 13, 2007
[Angiogenesis and breast cancer]Thomas Bachelot, Isabelle Ray-Coquard, Philippe Cassier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2013
Reply to J.-H. Choi et alThomas Bachelot, Claire Cropet, Isabelle Ray-Coquard, et al.
Cancer Treatment and Research|June 26, 2004
Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomasJean-Yves Blay, Isabelle Ray-Coquard, Laurent Alberti, et al.
Current Oncology Reports|August 16, 2014
High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approachesCharles-André Philip, Patricia Pautier, Florence Duffaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Soft Tissue and Uterine LeiomyosarcomaSuzanne George, César Serrano, Martee L Hensley, et al.
Ebiomedicine|October 10, 2020
Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2025
Controversies in the organization and structure of management for rare tumorsIsabelle Ray-Coquard, Jonathan Ledermann, Anna DeFazio, et al.
Journal for Immunotherapy of Cancer|March 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, et al.
Pageof 55

Showing results (51-60 of 548) with videos related to

Sort By:
Pageof 55
Bulletin Du Cancer|March 2, 2023
[Homologous recombination deficiency in epithelial ovarian cancers: from molecular characterization to patient journey]Stanislas Quesada, Jérôme Solassol, Isabelle Ray-Coquard, et al.
Seminars in Cancer Biology|September 15, 2020
Challenges for immunotherapy for the treatment of platinum resistant ovarian cancerOlivia Le Saux, Isabelle Ray-Coquard, S Intidhar Labidi-Galy
Bulletin Du Cancer|September 13, 2007
[Angiogenesis and breast cancer]Thomas Bachelot, Isabelle Ray-Coquard, Philippe Cassier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2013
Reply to J.-H. Choi et alThomas Bachelot, Claire Cropet, Isabelle Ray-Coquard, et al.
Cancer Treatment and Research|June 26, 2004
Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomasJean-Yves Blay, Isabelle Ray-Coquard, Laurent Alberti, et al.
Current Oncology Reports|August 16, 2014
High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approachesCharles-André Philip, Patricia Pautier, Florence Duffaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Soft Tissue and Uterine LeiomyosarcomaSuzanne George, César Serrano, Martee L Hensley, et al.
Ebiomedicine|October 10, 2020
Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?Isabelle Ray-Coquard, Hélène Vanacker, Olivia Le Saux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2025
Controversies in the organization and structure of management for rare tumorsIsabelle Ray-Coquard, Jonathan Ledermann, Anna DeFazio, et al.
Journal for Immunotherapy of Cancer|March 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, et al.
Pageof 55